In line with the increased absorbed tumor dose of the albumin-binding radioligands, the tumor growth inhibition was much more pronounced after application of [177Lu]Lu-Ibu-DAB-PSMA and [177Lu]Lu-PSMA-ALB-56 than after injection of [177Lu]Lu-PSMA-617. Here, FOLH1 is linked to neoplasm.